LBPO.BCS01 · 生物信息与计算 · Late-Breaking

在肿瘤学空间转录组数据上对单模态与多模态基础模型进行基准评测的实用指南

A practical guideline for benchmarking unimodal and multimodal foundation models on spatial transcriptomics data in oncology

编号 LB159 展板 1 时间 4/20 09:00–12:00 区域 Section 54 主讲 Anna Wahl-Schaar, BS;MS
分会场 Late-Breaking Research: Bioinformatics, Computational Biology, Systems Biology, and Convergent Science 1
该海报暂无可下载的资料 AACR 官方页面

作者与单位 Authors & Affiliations

Anna C. Wahl (née Schaar), Dasha Valter, Lisa Sikkema, Stefan G. Stark, Zelda E. Mariet, Tokuwa Kanno, Ediem Al-Jibury, Tobias Heinen, Liam Gonzalez, Marin G. M. Scalbert

Bioptimus, Paris, France

摘要 Abstract

中文摘要
对肿瘤微环境分子与形态学结构的理解,越来越多地借助基础模型(foundation models,FMs)来实现:这类模型是在H&E、空间组学和/或分子数据上训练的大规模、复杂的机器学习架构。与此同时,用于在空间背景下测量分子特征的数据生成和实验检测在规模、分辨率和体量上不断增长,往往不再局限于仅数百个基因,而是在亚细胞分辨率下测量数千个特征。规模化的数据生成与复杂的、往往是黑箱式的模型两相结合,需要定义明确的基准和透明的基线,以指导从业者判断哪种方法最适合在特定数据上实现特定目标。然而,现有基准是以计算驱动的方式设计的,仅关注一组粗粒度的标签和基因。尽管此类基准能够较好地反映总体性能,但它们往往无法涵盖不同的疾病类型和下游应用场景——这些场景在实际中需要不同的数据类型、输出和评估指标。它们也无法体现基础模型更高层面的目标:促成新的生物学发现。最后,在内部或全新数据集上复现基准结果,往往受限于复杂的计算框架。本工作为在空间转录组数据上构建有意义的基础模型基准提供了建议,其定义为以下三者的结合:(a)有意义的简单基线;(b)在适应证和数据类型上多样化的数据集;(c)有意义的下游任务和可解释的指标。我们首先对当前利用空间转录组数据的基准工作及其设计选择和局限性进行全面综述。为增强现有基准,我们引入了一组基于肿瘤学中常见细胞和基因特征而设计的新任务和指标,并允许针对亚细胞空间转录组数据的不同处理选择。对于每个任务,我们还定义了一个简单、内存高效的基线,以便将当前及即将出现的基础模型的性能置于恰当的视角中加以衡量。最后,我们讨论了为基础模型定义未来基准数据集的有用指南。本工作引入的新任务和基准框架为寻求准确评估单模态和多模态空间组学基础模型这一不断演进领域的研究人员提供了关键工具集。
查看英文原文 English abstract
Understanding the molecular and morphological structure of the tumor microenvironment is increasingly approached by the use of foundation models (FMs): large-scale, complex machine learning architectures trained on H&E, spatial omics, and/or molecular data. In parallel, data generation and experimental assays measuring molecular features in their spatial context are growing in size, resolution and scale, often no longer limited to only a few hundred genes, but multiple thousand features measured at subcellular resolution. This combination of scaled data generation and complex, often black-box, models requires well-defined benchmarks and transparent baselines to guide practitioners in deciding which approach(es) will best suit a specific goal with specific data. However, existing benchmarks are designed in a computational driven manner and focus only on a coarse-grained set of labels and genes. Although such benchmarks can give a good indication on overall performance, they often fail to capture different disease types and downstream use-cases which in practice will require distinct data types, outputs, and evaluation metrics. They also fail to capture the higher-level aim of foundation models: enabling novel biological findings. Finally, reproducing benchmark results on internal or novel datasets is often limited by complex computational frameworks. This work provides recommendations for building meaningful benchmarks for foundation models on spatial transcriptomics data, as defined by the combination of (a) meaningful, simple baselines, (b) diverse datasets with respect to indication and data type, and (c) meaningful downstream tasks and interpretable metrics. We begin by providing a complete overview of current benchmarking efforts leveraging spatial transcriptomics data and their design choices as well as limitations. To enhance existing benchmarks, we introduce a new set of tasks and metrics designed on common cell and gene signatures present in oncology, and allow for different processing choices designed for subcellular spatial transcriptomics data. For each task we also define a simple, memory-efficient baseline in order to put the performance of current and upcoming foundation models into perspective. We conclude by discussing useful guidelines for defining future benchmarking datasets for foundation models. The novel tasks and benchmarking frameworks introduced in this work provide a crucial toolset to researchers seeking to accurately assess the evolving landscape of uni- and multimodal foundation models for spatial omics.
利益披露 Disclosure
A. C. Wahl (née Schaar), Bioptimus Employment. D. Valter, Bioptimus Employment. L. Sikkema, Bioptimus Employment. S. G. Stark, Bioptimus Employment. Z. E. Mariet, Bioptimus Employment. Google Stock. T. Kanno, Bioptimus Employment. E. Al-Jibury, Bioptimus Employment. T. Heinen, Bioptimus Employment. L. Gonzalez, Bioptimus Employment. M. G. M. Scalbert, Bioptimus Employment.

← 返回 AACR 2026 检索